News The
company has announced the proposed transfer of the listing of and quotation for
the entire stock from the ACE market to the MAIN market of Bursa Malaysia.
It also proposed a 1-for-2 rights issue, a 1-for-2 bonus
issue for every two rights shares subscribed and one free warrant for every one
rights share subscribed by the entitled shareholders.
Based on the current outstanding shares, the bonus and
rights issues entail up to 184.0m additional new shares and another 122.7m
warrants.
The entitlement date will be determined later pending
approvals from Bursa Malaysia Securities, Securities Commission, shareholders
and others. The exercise is expected to be completed in 2Q2013.
Comments We
are positive on the proposal as we expect the exercise to enhance Cuscapi’s
liquidity and reward shareholders, which may potentially re-rate the stock.
They are not entirely surprising given its sizeable retained earnings reserve
to the share capital at the ratio of 1.5:1.
Assuming full conversion of the warrants and the new
issuance, the company’s share base will increase 125% to 552.0m. The total
proceeds that would be raised from the rights and full warrants conversion is
RM62.6m (RM29.3m from the rights and RM33.1m from the warrants based on the
indicative issue price of RM0.24 per rights and the indicative warrants’
exercise price of RM0.27 per piece).
Based on the latest closing price of RM0.325, the
theoretical exall price is estimated at RM0.255. As such, the warrants are slightly
out-the-money.
In our earnings model, we assume gradual conversion of 20% each
year for the next five years. As a result, the share base will increase by 5.7%
and 5.4% for FY13E and FY14E.
Outlook We believe the company will continue to
strengthen the contributions from its overseas units. In fact, its South East
Asia and China regional operations have registered 2-year revenue CAGR(s) of
42.8% and 121.3%, respectively.
We are still looking forward to see the company concluding a
project with one of the biggest fast-food restaurant chains in Philippines in
the near future, which has been delayed since late last year.
Besides, we are also looking forward to a new product of the
company, which is currently in the trial run stage and could be one of the
growth drivers from 2013 onwards.
Forecast Due to the higher cost spent for its
regional expansion and not factored in by us earlier, coupled with the
back-loaded earnings contribution from regional and product expansions, we are
thus cutting Cuscapi’s FY12E-13E earnings by 27.0%-36.9% to RM6.5m-RM7.2m (from
RM8.9m-RM11.4m), implying diluted FY12E-13E PERs of 16.9x-16.1x (vs. current
FY12E-13E PERs of 12.4x-11.1x).
Rating Maintain MARKET PERFORM.
Valuation We
have downgraded our
TP on Cuscapi
to RM0.36 (ex-all: RM0.27), from RM0.41 previously,
implying diluted FY12E-13E PERs of 17.0x-16.1x (vs. FY12E-13E PERs of
12.4x-11.1x).
Risks Delay in its projects implementation
Source: Kenanga
No comments:
Post a Comment